StockData
Nurix Therapeutics, Inc. logo

Nurix Therapeutics, Inc. (NRIX) stock

NRIXNasdaqPharmaceutical PreparationsFiscal year ends November 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 13, 2026Score 15/3073% below fair value
$14.10−0.14 (-0.98%)

Close on Nov 18, 2026Market cap $1.54BP/E 6.1Yield 0.00%

Nurix Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Nurix Therapeutics's pe ratio was 7.1× on Nov 11, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20267.1×–

More Nurix Therapeutics figures

See a number that looks wrong?